Skip to main
TELO
TELO logo

TELO Earnings Dates & Reports

TELO Most Recent Earnings

Report DateFeb 4, 2025
Period EndingQ4 2024
Est. EPS-$0.05
Actual EPS-$0.08
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

TELO Earnings per Share (EPS) History

Signup for full access
Browse free

TELO Latest Earnings

The value each TELO share was expected to gain vs. the value each share gained.

TELO reported its most recent earnings on Feb 4, 2025 for Q4 2024, posting earnings per share (EPS) of -$0.08. This exceeded analysts' expectations of -$0.05 by 60.00%, marking a Miss.

For comparison, Telomir Pharmaceuticals Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 02/04/2025, with analysts projecting an EPS of $0.

TELO Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2024Feb 4, 2025
-$0.05-$0.08+60.00%
DeckReportListen

TELO Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Telomir Pharmaceuticals Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

TELO Earnings FAQs

TELO last reported earnings on Feb 4, 2025 for Q4 2024, posting an EPS of -$0.08, which Miss the estimate of -$0.05 by 60.00%.

For Q4 2024, TELO reported an EPS of -$0.08, missing analysts' estimate of -$0.05 by 60.00%.

For Q4 2024, TELO Miss expectations with an actual EPS of -$0.08 vs. an estimated EPS of -$0.05.

Following the last earnings report on Feb 4, 2025, TELO's stock price moved — from — to —.

The next TELO earnings call is scheduled for Feb. 4, 2025, where executives will discuss financial results and outlook.

Telomir Pharmaceuticals Inc (TELO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.